PhaseBio Pharmaceuticals, Inc.
METALLOENZYME INHIBITOR COMPOUNDS
Last updated:
Abstract:
Provided are compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.
Status:
Application
Type:
Utility
Filling date:
17 Jun 2021
Issue date:
21 Oct 2021